DEBTPC Stock Latest News
Company AnnouncementsActive Biotech Sets June Timetable for 1:100 Reverse Share Split5M ago
Company AnnouncementsActive Biotech AGM Backs Reverse Share Split and Expands Capital Raising Mandate5M ago
Company AnnouncementsActive Biotech Cleared to Resume Tasquinimod Myelofibrosis Trial in Europe5M ago
Company AnnouncementsActive Biotech’s LION Study Backs Laquinimod’s Potential in Posterior Eye Disease6M ago
Company AnnouncementsActive Biotech Calls 2026 AGM, Maintains Board and Withholds Dividend6M ago
Company AnnouncementsActive Biotech Wins Approval to Resume Expanded Tasquinimod Myelofibrosis Trial8M ago
Company AnnouncementsActive Biotech Names Shareholder-Backed Nomination Committee Ahead of 2026 AGM9M ago
Company AnnouncementsActive Biotech Secures Funding Through Successful Rights Issue10M ago
Company AnnouncementsActive Biotech Secures US Patent for Tasquinimod Formulation11M ago- Company AnnouncementsActive Biotech Launches Rights Issue to Fund Key Projects11M ago
Company AnnouncementsActive Biotech’s Tasquinimod Shows Promise in Myelofibrosis Treatment11M ago
Company AnnouncementsActive Biotech Announces SEK 70 Million Rights Issue11M ago
- Company AnnouncementsActive Biotech Secures SEK 70 Million for Key Drug Developments1y ago
- Company AnnouncementsActive Biotech Announces Extraordinary General Meeting for Strategic Changes1y ago
Company AnnouncementsActive Biotech Reports Positive Phase I Results for Laquinimod Eye Drops1y ago
Company AnnouncementsActive Biotech Updates on Laquinimod and Tasquinimod Development Programs1y ago
Company AnnouncementsActive Biotech Highlights Positive LION Study Results for Laquinimod Eye Drops1y ago